These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7931254)

  • 1. The acute effect of the bioprecursor of the selective brain MAO-A inhibitor, MDL 72392, on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; Yuwiler A; Palfreyman MG
    J Neural Transm Suppl; 1994; 41():377-9. PubMed ID: 7931254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; McIntyre IM; White K
    J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
    Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
    J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
    Oxenkrug GF; Requintina PJ; Yuwiler A
    J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
    Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
    Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronopharmacological study of moclobemide effect on the rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; White K; Yuwiler A
    J Neural Transm Suppl; 1994; 41():335-7. PubMed ID: 7931247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition.
    King TS; Richardson BA; Reiter RJ
    Mol Cell Endocrinol; 1982 Mar; 25(3):327-38. PubMed ID: 6279462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats.
    Oxenkrug GF; Requintina PJ; Correa RM; Yuwiler A
    J Neural Transm Suppl; 1994; 41():249-52. PubMed ID: 7931233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
    Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
    J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of isatin (tribulin) on metabolism of indoles in the rat brain and pineal: in vitro and in vivo studies.
    Yuwiler A
    Neurochem Res; 1990 Jan; 15(1):95-100. PubMed ID: 1691454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
    Treseder SA; Rose S; Summo L; Jenner P
    J Neural Transm (Vienna); 2003 Mar; 110(3):229-38. PubMed ID: 12658372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
    Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
    J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbidopa effect on rat brain monoamine oxidase and pineal melatonin.
    McIntyre IM; McCauley RB; Filipowicz C; Oxenkrug GF
    Biol Psychiatry; 1985 Jul; 20(7):809-11. PubMed ID: 4005339
    [No Abstract]   [Full Text] [Related]  

  • 15. MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
    Zreika M; Fozard JR; Dudley MW; Bey P; McDonald IA; Palfreyman MG
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):243-54. PubMed ID: 2597310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats.
    Oxenkrug GF; McIntyre IM; Requintina PJ; Duffy JD
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):895-902. PubMed ID: 1722343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
    Fagervall I; Ross SB
    J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-acetylserotonin and hypotensive effect of MAO-A inhibitors].
    Oxenkrug GF
    Vopr Med Khim; 1997; 43(6):522-6. PubMed ID: 9503569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of MAO-A inhibition and cold-immobilization stress on N-acetylserotonin and melatonin in SHR and WKY rats.
    Oxenkrug GF; Requintina PJ
    J Neural Transm Suppl; 1998; 52():333-6. PubMed ID: 9564635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.
    Henriot S; Kuhn C; Kettler R; Da Prada M
    J Neural Transm Suppl; 1994; 41():321-5. PubMed ID: 7931245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.